Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Highlights

Genopole strengthens its ties with the Research Triangle Park


#Biotechnology #International #Innovative Therapies #Bioproduction
Alexis Biton and Paul Carouen - Genopole - visiting the Research Triangle Park (USA) accompanied by 3 Genopole's companies Alexis Biton and Paul Carouen - Genopole - visiting the Research Triangle Park (USA) accompanied by 3 Genopole's companies

From Monday March 20 to Thursday March 24, Genopole’s Partnership & Business Development team visited the Research Triangle Park biopark in North Carolina to strengthen scientific and industrial collaborations.

Located between three major universities (Duke University, NC State, UNC-Chapel Hill), Research Triangle Park is the largest research park in the United States. Its 7,000 acres are home to hundreds of companies, including science and technology firms, government agencies, academic institutions, start-ups, and other nonprofit organizations.

Genopole’s Partnership & Business Development team visited the park in mid-March, as part of a ten-year partnership to open the Genopole ecosystem to the US.
Three Genopole companies took part in this trip, met with investors, companies and academics and explored innovation and business opportunities in cutting-edge biotechnology fields: Cell Environment led by Radhia M’kacher, Biomede represented by Patricia Gifu and ABCell-Bio led by Mélanie Lavergne, who comments:

Citation

We were delighted to take up the opportunity offered to us by Genopole, which is in line with our ambition to develop new international research partnerships. We discovered an extremely rich territory, with universities, major biotech companies and hospitals, and met several of the site’s players. We presented our know-how in cell production, R&D and services in cell culture that we offer to public and private research laboratories. All these meetings open great prospects for collaborations and partnerships.

Strengthening synergies with industry and academia

The Genopole team, a pioneering biocluster in the field of innovative therapies, met with the managers of the recently opened Plant Science Building dedicated to the biomanufacturing sector and its biomanufacturing center, the Golden LEAF Biomanufacturing Training and Education Center (BTEC), which trains students in industrial manufacturing processes with full-scale equipment in a controlled environment.

On the academic level, the Duke campus, one of the most selective university in the southern United States (ranked 20th in the 2021 Thes-QS World University Ranking), renowned for its cutting-edge research, opened its doors to build the first links towards future collaborations. The mission also allowed for several BtoB meetings with biotech companies located in the Research Triangle Park, who are interested in establishing contacts with France.

On the basis of the links built, the Partnership and Prospecting Department will connect with the Research Triangle Park ecosystem, other genopolitan companies with a project to develop in the United States.

Contact for your international development projects

Alexis Biton

alexis.biton@genopole.fr
+33 6 07 80 93 38

Paul Caroen

paul.caroen@genopole.fr
+33 07 60 67 69 39

Article posted on 19 April 2023

Partager
Highlights

The latest news


Laboratoire de R&D - Abolis - campus Genopole

Abolis raises €35 million from an international consortium

Abolis has reached another milestone in its upscaling objectives. Convinced by the pertinence and robustness of its technology, an international consortium of industrials and funders will provide €35 million to the company.

Discover
Hélène Virasith, Program manager à Genopole, a accompagné trois startups génopolitaines Nutropy, AuraLIP et Onima au salon Futur Food Tech de Chicago - Juin 2024

Genopole at the Future FoodTech 2024 – Chicago

Genopole was in Chicago on June 17 and 18 for the Future Food Tech conference. Genopole® accompanied three of the biocluster's companies developing more sustainable food: Nutropy, AuraLIP and Onima. This was an opportunity for them to get noticed by major US groups and investors, and to gain an insight into North American market trends.

Discover
La délégation Genopole à BIO USA 2024

Genopole at BIO International 2024

The Genopole team at the BIO International Convention in San Diego pursued three main objectives: promote Genopole accompaniment to attract new talent, highlight biocluster companies and gather information on market and regulatory tendencies.

Discover
ACS Publication - Cover May 2024 - qui contient la publication du Lambe sur les nanopores

Lambe: A new milestone on the path to nanopore-based precision diagnostics

June 2024- Lambe has demonstrated the ability of an aerolysin nanopore to discriminate enantiomeric forms of peptide biomarkers useful for medical diagnostics.

Discover
Visite de la délégation

Genopole and the Netherlands: together to accelerate the development of alternative proteins

Genopole welcomed a Dutch delegation of close to 20 company representatives and alternative proteins researchers. The objective of the visit was to explore possibilities for research and business partnerships aimed at the development of new foods capable of meeting the future's nutritional, environmental, health, business and gustatory demands.

Discover
©Lionel Antoni - Plateforme d'irradiation expérimentale du LRGK - Plateforme génopolitaine mutualisée avec les acteurs de la communauté scientifique francilienne

The Experimental Irradiation Platform to serve the Île-de-France scientific community

Genopole is making available to the Île-de-France scientific community an Experimental Irradiation Platform equipped with a state of the art generator

Discover
Laina Freyer directrice scientifique, Felome

Felome Launches the Commercialization of Genetic Analyses for Companion Cats

Felome will begin the commercialization of a service offering genetic analyses for companion cats, to reveal their predispositions to over 50 diseases, identify their main physical traits, and their similarities with 14 types of breeds.

Discover
Lauréats de la promo 3 du programme Gene.iO - Genopole

Three Gene.iO whiz kids rewarded for their innovations

Three Gene.iO whiz kids, Alga Biologics, Fungu'it and Alt Biotech, rewarded for their innovations. Alga Biologics was among the 35 start-ups included in the French Blue Tech Index. Fungu'it and Alt Biotech, were selected to participate in 212 Founders, a start-up accompaniment and financing program by CDG Invest.

Discover
l'équipe iGEM 2023 Evry Paris-Saclay - Médaille d'or et p

A prize and gold for the 2023 Évry Paris-Saclay iGEM team

The international synthetic biology competition iGEM celebrated its 20th anniversary. From across the globe, the event drew more than 7,000 students in 400 teams from 66 countries. Genopole was there, among other actors in synthetic biology, to present the biocluster's advantages at its stand, and support the 17 students of the Évry Paris-Saclay team and their outstanding project, OptoGenEYEsis.

Discover
Genopole en mission exploratoire au Japon et en Corée du sud - octobre 2023

An exploratory mission to Japan and South Korea for Genopole

Genopole sent a team to Japan and South Korea to present itself and several of its accompanied businesses to major pharmaceutical corporations, investors and Asian bioclusters curious about biotechnological innovations and open to international partnerships.

Discover
Ibisc - Genopole's Laboratory

IBISC – Structure prediction for RNA complexes

passes a milestone in structure prediction for RNA complexes, key players in cell biology.

Discover
IBISC: A first predictive tool for the emerging field of bifunctional RNA

IBISC: A first predictive tool for the emerging field of bifunctional RNA

The IBISC laboratory has developed IRSOM2, an unprecedented bioinformatics tool for the prediction of bifunctional RNA, a relatively recently discovered class of RNA showing both an ability to code for proteins and an ability to perform biological roles.

Discover
Spectrométrie de masse à très haute spécificité - de la plateforme

Very-high-selectivity mass spectrometry

The mass spectrometry platform has acquired a Select Series Cyclic IMS system, an instrument with an unmatched ability to separate, characterize and quantify molecular species in complex samples.

Discover
Integrating informatics, structural biology and in vivo exploration for the discovery of new medicines

SABNP & Synsight: discovery of new medicines

SABNP and Synsight have validated an integrated, drug discovery approach uniting informatics, structural biology and in vivo exploration.

Discover
D4

D4Gen Hackathon: 48 hours and not a minute more to produce a digital tool for life sciences

The weekend event united more than 40 engineers, researchers and students, all specialists in and impassioned by the rapidly growing field of artificial intelligence.

Discover
Visite du nouveau laboratoire d'Enalees lors de son inauguration

Enalees – a new proteomics laboratory

On Thursday, 6 April, Enalees inaugurated their new proteomics development and production laboratory for the veterinary market.

Discover
Lambe - Genopole's laboratory

Lambe: Detecting coagulation biomarkers with a natural nanopore

The Lambe laboratory showed proof of concept for a coagulation biomarker detection technology based on a natural nanopore.

Discover
Andrew Tolonen's team within the unit of Genomics Metabolics (Genoscope - CEA)

Genoscope: Biomanufacturing with bacteria

A team led by Andrew Tolonen has developed a method to optimize the genetic engineering of Clostridium genus bacteria for biotech applications

Discover
l’équipe « Dystrophies musculaires progressives » du laboratoire Généthon

Shining light on a key mechanism of Duchenne muscular dystrophy

A Genethon team has provided new insights on a complex genetic mechanism involved in mitochondrial dysfunction in Duchenne muscular dystrophy.

Discover
A trio of genome sites associated with arterial hypertension

A trio of genome sites associated with arterial hypertension

Researchers from the CNRGH and PARCC have identified three loci associated with an increased risk of developing primary hyperaldosteronism, a leading cause of arterial hypertension.

Discover
View all >
With the support from
Région île de France